- Home
- TRVG vs LRMR Comparison
TRVG vs LRMR Comparison
Compare TRVG & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVG
- LRMR
- Stock Information
- Founded
- TRVG 2005
- LRMR N/A
- Country
- TRVG Germany
- LRMR United States
- Employees
- TRVG N/A
- LRMR N/A
- Industry
- TRVG EDP Services
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- TRVG Technology
- LRMR Health Care
- Exchange
- TRVG Nasdaq
- LRMR Nasdaq
- Market Cap
- TRVG 278.1M
- LRMR 309.8M
- IPO Year
- TRVG N/A
- LRMR N/A
- Fundamental
- Price
- TRVG $3.37
- LRMR $3.96
- Analyst Decision
- TRVG Buy
- LRMR Strong Buy
- Analyst Count
- TRVG 4
- LRMR 8
- Target Price
- TRVG $4.50
- LRMR $17.88
- AVG Volume (30 Days)
- TRVG 64.3K
- LRMR 1.3M
- Earning Date
- TRVG 11-04-2025
- LRMR 10-29-2025
- Dividend Yield
- TRVG N/A
- LRMR N/A
- EPS Growth
- TRVG N/A
- LRMR N/A
- EPS
- TRVG N/A
- LRMR N/A
- Revenue
- TRVG $592,176,160.00
- LRMR N/A
- Revenue This Year
- TRVG $18.39
- LRMR N/A
- Revenue Next Year
- TRVG $11.42
- LRMR N/A
- P/E Ratio
- TRVG N/A
- LRMR N/A
- Revenue Growth
- TRVG 7.39
- LRMR N/A
- 52 Week Low
- TRVG $1.60
- LRMR $1.61
- 52 Week High
- TRVG $5.83
- LRMR $9.50
- Technical
- Relative Strength Index (RSI)
- TRVG 48.68
- LRMR 54.10
- Support Level
- TRVG $3.20
- LRMR $3.78
- Resistance Level
- TRVG $3.39
- LRMR $4.26
- Average True Range (ATR)
- TRVG 0.14
- LRMR 0.27
- MACD
- TRVG 0.03
- LRMR -0.00
- Stochastic Oscillator
- TRVG 54.13
- LRMR 55.14
About TRVG trivago N.V.
trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and All other countries.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.